Cenexi: Humanigen, Cenexi Ink Manufacture Pact For COVID-19 Candidate, Lenzilumab, In France

Humanigen Inc (NASDAQ: HGEN) has selected Cenexi as a preferred supplier of lenzilumab in France and the European Union. Cenexi is a French CDMO specializing in the formulation, analytical development, and manufacture of complex molecule drugs. The initial step of the collaboration includes executing a Master Supply Agreement providing for Cenexi to provide aseptic fill and finish services for lenzilumab ...Full story available on Benzinga.com